Skip to main content

Trokendi XR

NDC 17772-104 · Supernus Pharmaceuticals, Inc.

Generic nametopiramate
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
Active ingredient(s)TOPIRAMATE
Strength200 mg/1
Pharmacologic classCytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Decreased Central Nervous System Disorganized Electrical Activity [PE]
Marketing categoryNDA

Packages

17772-104-01 — 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-104-01)

17772-104-07 — 7 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-104-07)

17772-104-10 — 5 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-104-10)

17772-104-12 — 7 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (17772-104-12)

17772-104-30 — 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (17772-104-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0832-1075 — Topiramate, 0904-6928 — topiramate, 0904-6929 — topiramate, 10370-365 — Topiramate, 10370-366 — Topiramate, 10370-367 — Topiramate, 10370-368 — Topiramate, 17772-101 — topiramate, 17772-102 — topiramate, 17772-103 — topiramate, 23155-894 — topiramate spinkle, 24979-210 — Topiramate, 24979-211 — Topiramate, 27241-227 — Topiramate, 27241-228 — Topiramate, 27241-229 — Topiramate, 27241-230 — Topiramate, 27241-296 — Topiramate, 27241-297 — Topiramate, 27241-298 — Topiramate, +289 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.